Volume 125, Issue 4 pp. 782-789
ORTHOPEDICS

Multimodal therapy for synchronous bone oligometastatic NSCLC: The role of surgery

Maria Teresa Congedo

Corresponding Author

Maria Teresa Congedo

Department of Thoracic Surgery, Fondazione Policlinico Universitario “A.Gemelli” IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy

Correspondence Maria Teresa Congedo, Department of Thoracic Surgery, Fondazione Policlinico Universitario “A. Gemelli” IRCCS; Università Cattolica del Sacro Cuore, Largo A Gemelli, 8, 00168 Rome, Italy.

Email: [email protected]

Search for more papers by this author
Dania Nachira

Dania Nachira

Department of Thoracic Surgery, Fondazione Policlinico Universitario “A.Gemelli” IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy

Search for more papers by this author
Luca Bertolaccini

Luca Bertolaccini

Department of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, Milan, Italy

Search for more papers by this author
Marco Chiappetta

Marco Chiappetta

Department of Thoracic Surgery, Fondazione Policlinico Universitario “A.Gemelli” IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy

Search for more papers by this author
Edoardo Zanfrini

Edoardo Zanfrini

Department of Thoracic Surgery, Fondazione Policlinico Universitario “A.Gemelli” IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy

Search for more papers by this author
Elisa Meacci

Elisa Meacci

Department of Thoracic Surgery, Fondazione Policlinico Universitario “A.Gemelli” IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy

Search for more papers by this author
Maria Letizia Vita

Maria Letizia Vita

Department of Thoracic Surgery, Fondazione Policlinico Universitario “A.Gemelli” IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy

Search for more papers by this author
Filippo Lococo

Filippo Lococo

Department of Thoracic Surgery, Fondazione Policlinico Universitario “A.Gemelli” IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy

Search for more papers by this author
Ettore D'Argento

Ettore D'Argento

Department of Medical Oncology, , Fondazione Policlinico Universitario “A. Gemelli” IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy

Search for more papers by this author
Lorenzo Spaggiari

Lorenzo Spaggiari

Department of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, Milan, Italy

Search for more papers by this author
Stefano Margaritora

Stefano Margaritora

Department of Thoracic Surgery, Fondazione Policlinico Universitario “A.Gemelli” IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy

Search for more papers by this author
First published: 17 December 2021
Citations: 1

Maria Teresa Congedo and Dania Nachira contributed equally.

Meeting presentation: The paper was presented as a poster at the ESTS Annual meeting 2020 (1st ESTS virtual Congress, October 2–3, 2020).

Abstract

Objectives

The study aimed to assess the feasibility of radical surgical treatment for selected bone-oligometastatic non-small cell lung cancer (NSCLC) patients and to identify prognostic factors associated with survival.

Materials and methods

The clinical records of 27 patients with bone synchronous oligometastatic NSCLC were retrospectively analyzed.

Results

Thirteen (48.1%) bone metastases were treated by surgery and 14 (51.9%) by local radiotherapy. Eighteen (66.7%) patients underwent induction chemotherapy before lung surgery, and 3 (11.1%) concurrent radiotherapy. Pulmonary surgery was a major lung resection in 23 (85.2%) cases. Intraoperative and 30-days mortality was null. Only one major (ARDS) and 10 (37.04%) mild complications (like air leakage, arrhythmia, and mucus retention) were recorded. 1-year and 5-years OS from the diagnosis and 1-year, 3- years disease-free survival (DFS) were 96%, 38%, and 66%, 30%, respectively. After stepwise Cox regression analysis, local recurrence (p = 0.05) and metachronous metastases (p = 0.04) maintained their independent prognostic value as overall survival negative determinants. Nodal upstaging (p = 0.04) and nonsurgical treatment of bone lesion (p = 0.03) turned out to be independent risk factors for shorter DFS; the vertebral localization of bone metastases showed only a remarkable trend towards significance (p = 0.06) as a risk factor for a worse DFS.

Conclusions

In selected patients, surgical treatment of primary NSCLC and bone synchronous metastasis seems to be safe and feasible and rewarding survivals may be expected.

CONFLICT OF INTERESTS

The authors declare that there are no conflict of interests.

DATA AVAILABILITY STATEMENT

The data that support the findings of this study are available from the corresponding author upon reasonable request.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.